Edwards Lifesciences Corporation Common Stock vs Roundhill S&P 500 0DTE Covered Call Strategy ETF — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $83.84 (market cap $48.56B), while Roundhill S&P 500 0DTE Covered Call Strategy ETF trades at $38.66 (market cap $330.98M). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 146.7× Roundhill S&P 500 0DTE Covered Call Strategy ETF's market cap, and Edwards Lifesciences Corporation Common Stock is trading nearer its 52-week high, Roundhill S&P 500 0DTE Covered Call Strategy ETF nearer its low. Which is the better fit depends on your goals.
| EW | XDTE | |
|---|---|---|
Market Cap | $48.56B | $330.98M |
Volume | 6,520,488 | 194,030 |
Sector | Health | Income / Options Overlay |
52-Week High | $95.18 | $44.76 |
52-Week Low | $72.65 | $36.00 |
Enterprise Value | $45.01B | — |
Typical Hold Time | — | 54 Days |
Trailing returns across standard periods
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →XDTE is an actively managed ETF that utilizes a synthetic covered call strategy on the S&P 500 Index using zero-days-to-expiration (0DTE) options. It seeks to provide high weekly income and overnight exposure to the index while mitigating some volatility through daily option premium harvesting.
Read more on XDTE →